Table 2.
TCM | Year | Patients | Period | Study design | Microbes | Outcomes |
---|---|---|---|---|---|---|
Berberine | Zhang et al., 2020 (57) | 409 Patients with T2D treated with either berberine alone, probiotic+berberine, probiotic alone or placebo. | 12 weeks | Randomized, double-blind, placebo-controlled trial | Berberine ↓ Ruminococcus bromi | Berberine reduced HbA1c, fasting and postprandial plasma glucose, fasting plasma triglyceride, total and low-density lipoprotein cholesterol |
GQD | Xu et al., 2015 (58) | 187 patients with T2D treated with either GQD or placebo | 12 weeks | Randomized double-blinded placebo-controlled clinical trial | GQD ↑ Faecalibacterium prausnitzii | GQD reduced the mean fasting plasma glucose and HbA1c |
AMC | Tong et al., 2018 (59) | 100 patients with T2D treated with either the metformin or AMC | 12 weeks | Randomized, open labelled randomized study RCT | AMC ↑ Faecalibacterium spp. | AMC reduced plasma glucose and lipids |
GQD, Gegen Qinlian Decoction; AMC, specifically designed herbal formula (no full name provided).